Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

T. Sen; V.R. Curovic; N. Jongs; G.D. Laverman; A. Kooy; F. Persson; P. Rossing; H.J.L. Heerspink

doi:10.1111/dom.15109

Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

T. Sen
, V.R. Curovic
, N. Jongs
, G.D. Laverman
, A. Kooy
, F. Persson
, P. Rossing
, H.J.L. Heerspink^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

2 Citations (Scopus)

5 Downloads (Pure)

Original language	English
Pages (from-to)	2413-2418
Number of pages	6
Journal	Diabetes, Obesity and Metabolism
Volume	25
Issue number	8
DOIs	https://doi.org/10.1111/dom.15109
Publication status	Published - Aug 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

ARB
DPP-4 inhibitor
JAK-STAT inhibitor
SGLT2 inhibitor
Baricitinib
Empagliflozin
Inflammation
Inflammatory markers
Linagliptin
Telmisartan

Access to Document

10.1111/dom.15109Licence: CC BY-NC-ND

Diabetes Obesity Metabolism - 2023 - Sen - Effects of albuminuria‐lowering treatments on inflammation markers A post hocFinal published version, 901 KBLicence: CC BY-NC-ND

Cite this

@article{11504bf3fb1444cca82826c4292bd8d4,

title = "Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials",

keywords = "ARB, DPP-4 inhibitor, JAK-STAT inhibitor, SGLT2 inhibitor, Baricitinib, Empagliflozin, Inflammation, Inflammatory markers, Linagliptin, Telmisartan",

author = "T. Sen and V.R. Curovic and N. Jongs and G.D. Laverman and A. Kooy and F. Persson and P. Rossing and H.J.L. Heerspink",

year = "2023",

month = aug,

doi = "10.1111/dom.15109",

language = "English",

volume = "25",

pages = "2413--2418",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley",

number = "8",

}

TY - JOUR

T1 - Effects of albuminuria-lowering treatments on inflammation markers

T2 - A post hoc analysis from the ROTATE trials

AU - Sen, T.

AU - Curovic, V.R.

AU - Jongs, N.

AU - Laverman, G.D.

AU - Kooy, A.

AU - Persson, F.

AU - Rossing, P.

AU - Heerspink, H.J.L.

PY - 2023/8

Y1 - 2023/8

KW - ARB

KW - DPP-4 inhibitor

KW - JAK-STAT inhibitor

KW - SGLT2 inhibitor

KW - Baricitinib

KW - Empagliflozin

KW - Inflammation

KW - Inflammatory markers

KW - Linagliptin

KW - Telmisartan

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=utwente-ris&SrcAuth=WosAPI&KeyUT=WOS:000986615100001&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1111/dom.15109

DO - 10.1111/dom.15109

M3 - Letter

C2 - 37166080

SN - 1462-8902

VL - 25

SP - 2413

EP - 2418

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 8

ER -

Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

UN SDGs

Keywords

Access to Document

Other files and links

Cite this